Literature DB >> 9366670

Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors.

D M Jacobson1, R A Vierkant, E A Belongia.   

Abstract

OBJECTIVE: To determine the influence of certain potential risk factors on the occurrence of nonarteritic anterior ischemic optic neuropathy.
DESIGN: Case-control using 2 independent control groups, one involving a geographically defined population and the other involving patients who underwent a routine comprehensive medical evaluation.
SETTING: Multispecialty clinic in a rural setting providing primary, secondary, and tertiary care for residents of central and northern Wisconsin and the Upper Peninsula of Michigan. PATIENTS: Fifty-one patients older than 45 years with first ever acute nonarteritic anterior ischemic optic neuropathy. MAIN OUTCOME MEASURES: Potential risk factors defined using standardized definitions abstracted from the medical records, including diabetes, hypertension, hypercholesterolemia, coronary artery disease, tobacco use, chronic obstructive pulmonary disease, body mass index, hematocrit, and white blood cell count.
METHODS: Conditional logistic regression analyses, first using a univariate analysis and then employing a multivariate analysis using a forward selection process.
RESULTS: The geographically defined case-control multivariate analysis revealed that diabetes (odds ratio = 2.7, 95% confidence interval = 1.2-6.3, P = .02) and body mass index (odds ratio = 1.07, 95% confidence interval = 1.00-1.14, P = .08) were associated with case status. The comprehensive case-control multivariate analysis revealed that only diabetes (odds ratio = 5.0, 95% confidence interval = 1.4-17.3, P = .01) was a significant risk factor. The attributable risk estimation for diabetes was 0.21 and 0.27 for the geographically defined and comprehensive controls, respectively.
CONCLUSIONS: Diabetes seems to be a major risk factor for the development of nonarteritic anterior ischemic optic neuropathy. The low attributable risk estimation suggests that factors other than diabetes are important in the development of nonarteritic anterior ischemic optic neuropathy or in predisposing individuals to it.

Entities:  

Mesh:

Year:  1997        PMID: 9366670     DOI: 10.1001/archopht.1997.01100160573008

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  46 in total

Review 1.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Non-arteritic anterior ischemic optic neuropathy and thrombophilia.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-29       Impact factor: 3.117

3.  Pegylated interferon alpha-associated optic neuropathy.

Authors:  Kathleen T Berg; Bruce Nelson; Andrew R Harrison; Linda K McLoon; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

4.  Management of non-arteritic anterior ischemic optic neuropathy.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 3.117

5.  Association between visual status and mental health status in Thai rural elderly: a community-based study.

Authors:  Pear Pongsachareonnont; Nopphawan Uramphorn; Nuchanad Hounnaklang
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

6.  Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.

Authors:  Steven E Feldon
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 7.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

Review 8.  [Anterior ischemic optic neuropathy: Etiology, pathogenetic mechanisms and therapy].

Authors:  R Unsöld
Journal:  Ophthalmologe       Date:  2008-09       Impact factor: 1.059

9.  Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy.

Authors:  Yan Wang; Dale P Brown; Brant D Watson; Jeffrey L Goldberg
Journal:  J Vis Exp       Date:  2015-11-29       Impact factor: 1.355

10.  Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Ioannis Asproudis; Taxiarchis L Felekis; Spiridon Gorezis; Lefkothea Dova; Eleni Dokou; Georgios Vartholomatos; Miltiadis Aspiotis; Nikolaos I Kolaitis
Journal:  Open Ophthalmol J       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.